Atlas Trials

A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults

Clinical trial NCT04268420 · UNKNOWN

Trial details

NCT number
NCT04268420
Sponsor
U.S. Army Medical Research and Development Command
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Vaccine Reaction
Start date
2020-03-20
Primary completion
2023-07-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.